Global Drug Discovery Informatics Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Drug Discovery Informatics Industry Market Size Be by 2025?
The size of the drug discovery informatics market has seen a fast-paced expansion in recent times. The market value will surge from $3.69 billion in 2024 to $4.06 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.2%. Several factors contributed to this growth in the previous period, including advancements in genomics and proteomics, the growing complexity of drug targets, developments in structural biology, a boost in outsourcing, integration of pharmacogenomics, and strategies for drug repurposing.

What's the Long-Term Growth Forecast for the Drug Discovery Informatics Market Size Through 2029?
Anticipated brisk expansion is projected for the drug discovery informatics market in the upcoming years, with an expectation to scale up to $6.83 billion by 2029, progressing at a compound annual growth rate (CAGR) of 13.9%. The advancement throughout this period is associated with the growth of precision medicine, the prediction of drug-drug interaction, analysis of data derived from patients, development of biosimilars, and an increasing count of drug candidates. The period forecast illustrates significant trends such as the incorporation of AI and machine learning, application of digital twins in drug development, collaborative platforms, use of blockchain for data security, enhancement in imaging technologies, and the emergence of cloud-based informatics platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

What Are the Key Growth Drivers Fueling the Drug Discovery Informatics Market Expansion?
The escalating occurrence of multiple chronic diseases is anticipated to drive the expansion of the drug discovery informatics market in the future. Such chronic diseases, typically characterized as conditions that last for a year or more and require sustained medical intervention, or limit day-to-day activities, augment the need for drug discovery informatics. These systems facilitate enhancements in chronic disease management by enabling scientists to investigate intricate and impermanent molecular changes that indicate disease development and drug reactions. This leads to multi-faceted models of the complete hierarchical system in healthy, diseased, and treated conditions. For example, the World Health Organization, a Swiss-based United Nations organization tasked with global health matters, projected in their 2022 report that non-communicable diseases (NCDs) are likely to cause 41 million deaths, constituting 74% of all worldwide deaths. Annually, NCDs claim the lives of 17 million individuals before they reach 70, with 86% of these premature deaths occurring in low- and middle-income countries. The highest number of deaths annually are attributed to cardiovascular diseases (17.9 million), followed by cancer (9.3 million), chronic respiratory illnesses (4.1 million), and diabetes (2.0 million, inclusive of kidney disease deaths due to diabetes). Given these figures, the increasing incidence of multiple chronic diseases is fuelling the growth of the drug discovery informatics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8960&type=smp

What Are the Key Trends Driving Drug Discovery Informatics Market Growth?
Innovations in technology are becoming a significant trend in the drug discovery informatics sector. Major players in the market are zeroing in on the creation of technologically advanced solutions to maintain and solidify their position in the market. An example of this is the March 2023 launch of Connected Insights by Illumina Inc., an American biotech firm. Connected Insights is a novel cloud-based software that facilitates tertiary analysis for clinical next-generation sequencing (NGS) data. Its purpose is to simplify interpretation and reporting from diverse assay types, thereby allowing labs to escalate the utilization of NGS and minimize the timeframe of clinical reporting through the integration of third-party databases. It also aims to offer support for an array of applications, soon to involve whole-genome sequencing (WGS) for rare disease. The Illumina Connected Software is a comprehensive software ecosystem standardizing analysis tools and correlating data throughout the genomic workflow. By assimilating with Illumina sequencers and access to DRAGEN secondary analysis, the Illumina Connected Software provides an efficient, precise, and adaptable analysis environment that's prepared to scale based on each customer's workflow.

How Is the Drug Discovery Informatics Market Segmented?
The drug discovery informaticsmarket covered in this report is segmented -

1) By Service: In-House, Outsourced
2) By Modality: Cloud-Based Systems, In-Campus
3) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies

Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling, Other In-House Services
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services, Other Outsourced Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8960&type=smp

Which Companies Are Leading the Charge in Drug Discovery Informatics Market Innovation?
Major companies operating in the drug discovery informatics market include accenture* Plc., Certara Inc., Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products Inc., Jubilant Biosys Ltd., Selvita S.A., PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., ChemAxon Ltd., Amazon Web Services Inc., Schrödinger LLC., Core Informatics LLC, Informatics Matters Ltd., Tata Consultancy Services Limited, Novo Informatics Pvt. Ltd., IO Informatics Inc., GVK Biosciences Private Limited, Dassault Systèmes SE, Recursion Pharmaceuticals Inc., Cyclica Inc., Valence Discovery Inc., Valo Health Inc., Cognizant Technology Solutions Corporation, Wipro Limited, Mindtree Limited, Persistent Systems Limited, Mphasis Limited

Which Regions Are Leading the Global Drug Discovery Informatics Market in Revenue?
North America was the largest region in the drug discover informatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8960

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.